From July 23 to 25, 2025, a grand industry event bringing together global expertise in small animal healthcare was held at the Suzhou International Expo Center. The first Small Animal Veterinary Specialty Development Conference, hosted by the China Veterinary Medical Association, with the theme of "Strengthening the Foundation, Innovating, Improving Quality and Efficiency," became a milestone event in promoting the specialization of pet healthcare.

As an innovative force in the pet healthcare industry, Nanjing Zhenchong Medical Technology Co., Ltd. made a stunning appearance with its core products, leaving a significant mark at this industry-leading event.

In recent years, China's pet healthcare market has experienced explosive growth, reaching a market size of 84.06 billion yuan in 2024, accounting for 28% of the total pet economy. It is projected to exceed 100 billion yuan in 2025, reaching 108.7 billion yuan. Amid this booming development, pet tumor treatment has become a key area urgently requiring breakthroughs.

Data shows that the incidence of tumors in dogs is 6 times that of cats, and about 50% of dogs over 10 years old die from cancer. The incidence of mammary tumors in female dogs is as high as 43-50%.

However, traditional tumor treatments often involve large incisions, high pain levels, and long recovery periods, making it difficult to meet pet owners' demands for high-quality medical care. There is a huge technological gap in the field of minimally invasive tumor treatment for small animals.

Nanjing Zhenchong Medical Technology Co., Ltd., an innovative enterprise under Zhentai Microwave, has been deeply involved in animal medical technology research and development since its establishment in 2022. This time, it is making a major appearance at the exhibition with its animal tumor microwave ablation instrument, which is aimed at this clinical pain point.

This innovative device, the culmination of the R&D team's hard work, has caused a stir in the industry with its core advantages of being "minimally invasive, precise, safe, and efficient."

Compared with traditional surgery, it can achieve targeted tumor ablation without large incisions. Through the unique anti-scalding microwave physiotherapy radiator design, it can precisely destroy tumor tissue while protecting healthy cells to the maximum extent, greatly reducing the pain of animal treatment and the postoperative recovery period.

Compared to other minimally invasive ablation techniques, this device has advantages in terms of ease of operation, efficiency, and applicable tumor types, and is especially suitable for the treatment of common tumors in dogs and cats, such as skin and connective tissue tumors, breast tumors, and visceral tumors.

The demonstration area at the exhibition became the focus of attention. When the staff started the equipment to demonstrate the operation, the originally scattered crowd quickly gathered, and a long queue of people soon formed in front of the booth.

The outstanding performance at this exhibition stems from Nanjing Zhenchong Medical's profound technological foundation. As a technology company specializing in microwave technology applications, the company not only possesses core patents such as anti-scalding radiators, but has also established an interdisciplinary R&D team composed of veterinary clinical experts and microwave engineering technicians.

This "clinical needs-oriented + engineering technology implementation" R&D model ensures that products meet actual market demands from the very beginning. As Xin Shengpeng, Vice President of the China Veterinary Medical Association, commented during the exhibition tour: "Innovation in pet healthcare requires such truly clinically grounded technological breakthroughs; this is the core driving force for industry progress."

With personalized precision medicine becoming the industry's development direction, the successful demonstration of the animal tumor microwave ablation device has opened up a new path for minimally invasive and precise treatment of pet tumors. Although the exhibition has ended, the seeds of cooperation have been sown. Currently, the company has partnered with dozens of pet hospitals in China, accumulating hundreds of cases, and the process of obtaining market access certification in overseas markets is also progressing steadily.

In the future, Nanjing Zhenchong Medical will actively participate in the formulation of industry standards and promote the standardized application of animal microwave ablation technology. As the company's representative said at the exhibition, "Every technological breakthrough means that more pets can suffer less pain. We will use innovative technology as our pen to write a new chapter in the cause of animal health."

Follow Nanjing Zhenchong Medical for continuous updates on product clinical progress and industry trends. We look forward to witnessing every breakthrough in animal medical technology and contributing to building a harmonious ecosystem between humans and pets!

We offer flexible cooperation options, including purchasing, leasing, distribution, and OEM manufacturing. We welcome inquiries from individuals with animal tumor ablation needs.